Status | Study |
Active, not recruiting |
Study Name: Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer Condition: Metastatic Carcinoma in the Adrenal Cortex Recurrent Adrenal Cortex Carcinoma Date: 2016-03-16 Interventions: Other: Laboratory Biomarker Analysis |
Recruiting |
Study Name: Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma Condition: Adrenocortical Carcinoma Date: 2016-02-01 Interventions: Drug: Pembrolizumab |
Recruiting |
Study Name: Towards an Easy-to-use Adrenal Cancer/Tumor Identity Card Condition: Adrenal Gland Neoplasms Date: 2016-01-14 Interventions: Biological: omics identity card |
Completed |
Study Name: Efficacy and Safety of Posterior Retroperitoneoscopic Adrenalectomy: A Comparative Study Condition: Adrenal Mass Adrenal Disease Pheochromocytoma Date: 2015-11-15 Interventions: Procedure: Posterior retroperitoneoscopic adrenalectomy |
Recruiting |
Study Name: EUS-B-FNA vs EUS-FNA for Left Adrenal Gland Analysis in Lung Cancer Patients Condition: Suspected Left Adrenal Gland Metastasis in Lung Cancer Date: 2015-08-31 Interventions: Procedure: EUS-B-FNA followed by EUS-FNA for LAG analysis |
Recruiting |
Study Name: Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome Condition: Cushing's Syndrome Ectopic Corticotropin Syndrome Adrenal Date: 2015-06-08 Interventions: Drug: Osilodrostat Osilodrostat will be prescribed by the investigator. Osirodrostat 1 mg, 5 mg, 10 mg, |
Recruiting |
Study Name: Adrenal Venous Sampling in Patients With Overt or Subclinical Cushings Syndrome, and Bilateral Adrenal Tumors Condition: Cushing Syndrome Date: 2015-02-13 Interventions: Radiation: Adrenal venous sampling We go trough the femoral vein with a catheter up to the adrenal vein |
Recruiting |
Study Name: Surgery of Subclinical Cortisol Secreting Adrenal Incidentalomas Condition: Adrenal Incidentalomas Date: 2015-01-28 Interventions: Procedure: Laparoscopic surgical removal of the adrenal tumor |
Recruiting |
Study Name: Structured Evaluation of adRENal Tumors Discovered Incidentally - Prospectively Investigating the Testing Yield Condition: Adrenal Incidentaloma Adrenocortical Carcinoma Date: 2014-12-19 |
Completed |
Study Name: Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492 Condition: Adrenocortical Adenoma Endometrial Stromal Sarcomas Date: 2014-05-15 Interventions: Procedure: MRI, CT or ultrasound was permitted if MRI was contraindicated |